Cat: IPD-X39384

Recombinant Human LHX1 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    LHX1

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    LIM1

  • Species

    Human

  • Source

    E. coli

  • Tag

    N-His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P48742

  • Expression Region

    Met1~Gln191

  • Molecular Weight

    30kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

LHX1 (LIM homeobox 1) is a transcription factor that plays a crucial role in neurodevelopment, particularly in the formation of the brain's midline structures and the development of hypothalamic and pituitary tissues. Mutations or dysregulation of LHX1 have been linked to various neurodevelopmental disorders, including defects in the hypothalamus that can lead to hormonal imbalances. Recent studies have highlighted the potential of LHX1 as a target for therapeutic interventions, given its pivotal role in cell fate determination and differentiation during early development. Researchers have focused on producing recombinant LHX1 protein to investigate its functional underpinnings more thoroughly. By expressing and purifying LHX1 protein, scientists aim to elucidate its structural properties and regulatory mechanisms in a cellular context. This recombinant protein study is essential for understanding how LHX1 interacts with other proteins and DNA, thereby influencing gene expression patterns during critical phases of neural development. Further exploration of LHX1 may offer insights into its potential involvement in regenerative medicine and the treatment of developmental disorders, paving the way for novel strategies to mitigate the impacts of neurodevelopmental abnormalities.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US